Malignant neoplasm of bone and articular cartilage - Diagnostic scanning with a colloidal solution of thorium dioxide Factor
Last reviewed for CCPS 30 September 2002.
Preliminary questions [13164]
16278 there is some evidence that diagnostic scanning with a colloidal solution of thorium dioxide may be a factor in the development of the condition under consideration.
13169 the veteran has undergone diagnostic scanning with a colloidal solution of thorium dioxide at some time.
13186 the veteran underwent diagnostic scanning with a colloidal solution of thorium dioxide for treatment of an illness or injury which is identifiable.
the veteran underwent diagnostic scanning with a colloidal solution of thorium dioxide for treatment of the identified illness or injury before the clinical onset of malignant neoplasm of the bone or articular cartilage of side and site of the body.13188 — the veteran has established the causal connection between the diagnostic scanning with a colloidal solution of thorium dioxide and VEA service for the clinical onset of malignant neoplasm of the bone or articular cartilage.
13189 — the veteran has established the causal connection between the diagnostic scanning with a colloidal solution of thorium dioxide and operational service for the clinical onset of malignant neoplasm of the bone or articular cartilage.
or
13190 — the veteran has established the causal connection between the diagnostic scanning with a colloidal solution of thorium dioxide and eligible service for the clinical onset of malignant neoplasm of the bone or articular cartilage.
Clinical onset and operational service [13189]
13191 — the identified illness or injury for which the diagnostic scanning with a colloidal solution of thorium dioxide was undergone is causally related to operational service.
Clinical onset and eligible service [13190]
13192 — the identified illness or injury for which the diagnostic scanning with a colloidal solution of thorium dioxide was undergone is causally related to eligible service.